SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-015074
Filing Date
2024-05-07
Accepted
2024-05-07 16:07:44
Documents
16
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240503_8k.htm   iXBRL 8-K 28744
2 EXHIBIT 99.1 ex_666739.htm EX-99.1 70539
7 ex_666739img001.jpg GRAPHIC 3748
  Complete submission text file 0001437749-24-015074.txt   246927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20240507.xsd EX-101.SCH 3400
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240507_def.xml EX-101.DEF 11420
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240507_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240507_pre.xml EX-101.PRE 11580
19 EXTRACTED XBRL INSTANCE DOCUMENT opk20240503_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 24921845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)